Hearings, comment windows, dockets, and other milestones the pipeline extracts from the Federal Register, agency notices, and related public sources — not legal advice; verify with the primary docket.
DOT Rule Announcement
New testing procedures could impact workplace drug policies.
Comment period open
Public comments are invited on Medicaid/CHIP info collection.
Webinar on Colorado's Ibogaine Legislation
Key for understanding policy changes in psychedelic regulation.
Inside MEAI Webinar
Webinar may reveal key trial insights.
RFI on Psychedelic Therapies
Key opportunity to influence federal policy on psychedelic therapies.
Items are machine-extracted and scored for relevance; always check the primary agency docket or register notice before relying on a date. See the methodology & sources page and the research landscape for how we frame coverage.
Suggest a tool, topic, or improvement that would make this site more useful.